INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 436m ago
House PTR36m ago
SEC 13F35m ago
Robinhood Chain35m ago

Most active filers · 30d

  1. 01FWFogarty Patrick W0B / 206S206 trades$1.10M
  2. 02Kurtz George0B / 202S202 trades$48.06M
  3. 03SPSaba Capital Management, L.P.67B / 19S · 11 late86 trades$22.22M
  4. 04NYNissan Yitzhak82B / 0S · 79 late82 trades$2.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SJSheena Jonathan0B / 45S45 trades$3.01M
  9. 09CMCannon-Brookes Michael35B / 0S35 trades$11.72M
  10. 10SLSpeiser Michael L0B / 35S35 trades$14.00M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 189 insiders$1.02M
  3. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  4. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  5. SELLMGNIMAGNITE, INC.Nov 5 – Nov 198 insiders$2.81M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

74,191 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
CD
Conaway Jeffrey D.VP, CAO & Corp. Controller
CVICVR ENERGY INC
Option exercise
M—
3,526 sh
Dec 10, 2025Dec 12, 2025
Page 1665 of 1855
← PrevNext →
traded Dec 10, 2025
+2d
SEC Form 4

Evidence

9
NJ
Neumann Dane J.EVP & Chief Financial Officer
CVICVR ENERGY INC
Option exercise
M—
11.5K sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC Form 4

Evidence

9
SB
Stefanski Gavin BChief Experience Officer
TFSLTFS Financial CORP
Option exercise
M—
1,433 sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC Form 4

Evidence

9
CD
Conaway Jeffrey D.VP, CAO & Corp. Controller
CVICVR ENERGY INC
Option exercise
M—
1,489 sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC Form 4

Evidence

9
SB
Szwarcberg Javier B.Director, CHIEF EXECUTIVE OFFICER
SPRBSPRUCE BIOSCIENCES, INC.
Grant or award
A—
19.8K sh
Dec 11, 2025Dec 12, 2025
traded Dec 11, 2025
+1dSEC Form 4

Evidence

9
RJ
Rubino Andrew JChief Operating Officer
TFSLTFS Financial CORP
Option exercise
M—
2,900 sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC Form 4

Evidence

9
MD
Miller Steven DouglasVP, Chief Technology Officer
NYSESCSSTEELCASE INC
Grant or award
A—
148.5K sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC Form 4

Evidence

9
HN
Harmon NealDirector, Chief Executive Officer
ANGXAngel Studios, Inc.
Grant or award
A—
129.2K sh
Dec 12, 2025Dec 12, 2025
traded Dec 12, 2025
+0dSEC Form 4

Evidence

9
FK
Flynn Donna KVP, Chief People Officer
NYSESCSSTEELCASE INC
Grant or award
A—
148.2K sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC Form 4

Evidence

9
NJ
Neumann Dane J.EVP & Chief Financial Officer
CVICVR ENERGY INC
Option exercise
M—
6,607 sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC Form 4

Evidence

9
NJ
Neumann Dane J.EVP & Chief Financial Officer
CVICVR ENERGY INC
Option exercise
M—
5,077 sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC Form 4

Evidence

9
CD
Conaway Jeffrey D.VP, CAO & Corp. Controller
CVICVR ENERGY INC
Option exercise
M—
2,044 sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC Form 4

Evidence

9
MD
Miller Steven DouglasVP, Chief Technology Officer
NYSESCSSTEELCASE INC
Disposition to issuer
D—
66.0K sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC Form 4

Evidence

8
SF
Schaufeld FredrickDirector
TLSTELOS CORP
Gift
G—
25.0K sh
Dec 12, 2025Dec 12, 2025
traded Dec 12, 2025
+0dSEC Form 4

Evidence

8
MP
McDonnell Kevin PatrickCFO
AVAVAeroVironment Inc
Open-market sale · 10b5-1 plan
SELL$127K
511 sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC Form 4

Evidence

8
SF
Schaufeld FredrickDirector
TLSTELOS CORP
Gift
G—
35.0K sh
Dec 11, 2025Dec 12, 2025
traded Dec 11, 2025
+1dSEC Form 4

Evidence

8
HK
Hohenstein KenChief Revenue Officer
OSOneStream, Inc.
Tax withholding
F$112K
6,101 sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC Form 4

Evidence

7
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M$28K
133 sh
Dec 11, 2025Dec 12, 2025
traded Dec 11, 2025
+1dSEC Form 4

Evidence

7
Narkhede NehaDirector
CFLTConfluent, Inc.
Derivative conversion · 10b5-1 plan
C—
23.1K sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC Form 4

Evidence

7
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M$28K
133 sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC Form 4

Evidence

6
CM
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
ANIPANI PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$33K
400 sh
Dec 12, 2025Dec 12, 2025
traded Dec 12, 2025
+0dSEC Form 4

Evidence

5
RJ
Rubino Andrew JChief Operating Officer
TFSLTFS Financial CORP
Option exercise
M—
2,134 sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC Form 4

Evidence

5
PT
Power Luke ThomasSee Remarks
CAICaris Life Sciences, Inc.
Open-market sale · 10b5-1 plan
SELL$38K
1,400 sh
Dec 11, 2025Dec 12, 2025
traded Dec 11, 2025
+1dSEC Form 4

Evidence

5
RJ
Rubino Andrew JChief Operating Officer
TFSLTFS Financial CORP
Option exercise
M—
8,730 sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC Form 4

Evidence

5
WG
Wright Robert G.EVP
DKDelek US Holdings, Inc.
Tax withholding
F$48K
1,382 sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC Form 4

Evidence

5
PB
Pfeiffenberger BrentDirector, President and CEO
IPSCCentury Therapeutics, Inc.
Tax withholding
F$244
463 sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC Form 4

Evidence

5
RJ
Rubino Andrew JChief Operating Officer
TFSLTFS Financial CORP
Option exercise
M—
2,167 sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC Form 4

Evidence

4
AT
Arora TarunChief Accounting Officer
RNGRingCentral, Inc.
Open-market sale · 10b5-1 plan
SELL$79K
2,597 sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC Form 4

Evidence

3
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M$16K
98 sh
Dec 11, 2025Dec 12, 2025
traded Dec 11, 2025
+1dSEC Form 4

Evidence

3
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M$16K
98 sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC Form 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M—
1,313 sh
Dec 11, 2025Dec 12, 2025
traded Dec 11, 2025
+1dSEC Form 4

Evidence

0
WT
Weingarten TomerDirector, President, CEO
SSentinelOne, Inc.
Derivative conversion · 10b5-1 plan
C—
5,441 sh
Dec 11, 2025Dec 12, 2025
traded Dec 11, 2025
+1dSEC Form 4

Evidence

0
RM
Rizik MatthewDirector
RKTRocket Companies, Inc.
Open-market sale · 10b5-1 plan
SELL$47K
2,500 sh
Dec 12, 2025Dec 12, 2025
traded Dec 12, 2025
+0dSEC Form 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M—
1,313 sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC Form 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M—
1,729 sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC Form 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M—
1,274 sh
Dec 11, 2025Dec 12, 2025
traded Dec 11, 2025
+1dSEC Form 4

Evidence

0
RM
Rizik MatthewDirector
RKTRocket Companies, Inc.
Open-market sale · 10b5-1 plan
SELL$48K
2,500 sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC Form 4

Evidence

0
PT
Power Luke ThomasSee Remarks
CAICaris Life Sciences, Inc.
Option exercise · 10b5-1 plan
M—
37.5K sh
Dec 11, 2025Dec 12, 2025
traded Dec 11, 2025
+1dSEC Form 4

Evidence

0
RM
Rizik MatthewDirector
RKTRocket Companies, Inc.
Open-market sale · 10b5-1 plan
SELL$49K
2,500 sh
Dec 11, 2025Dec 12, 2025
traded Dec 11, 2025
+1dSEC Form 4

Evidence

0
PT
Power Luke ThomasSee Remarks
CAICaris Life Sciences, Inc.
Option exercise · 10b5-1 plan
M—
24.8K sh
Dec 11, 2025Dec 12, 2025
traded Dec 11, 2025
+1dSEC Form 4

Evidence